Prostate cancer is the second leading cause of cancer death among men in the United States. It is a common disease that effects 1 out of every 7 men. The good news is that early detection can assist in fighting this disease and scheduling annual prostate screenings can help identify this cancer in its early
New ProstAtak Clinical Trials
ProstAtak® is a new prostate cancer treatment trial for localized prostate cancer using gene therapy. This new cancer treatment trial is now available at our facilities and we are one of only two medical centers in the Houston area that offer this treatment trial. Click here for more information about the treatment and how to
